Pitcairn Company »

Ultragenyx Pharmaceutical shares owned by Pitcairn Company

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Pitcairn Company from 13F filings

Historical chart of Pitcairn Company investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Pitcairn Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Pitcairn Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $413k 8.6k 47.82

More positions owned by Pitcairn Company

Ishares Tr Russell 3000 Etf (IWV)
Direxion Shs Etf Tr Auspce Cmd Stg (COM)
Microsoft Corporation (MSFT)
Spdr Index Shs Fds Msci Acwi Exus (CWI)
Apple (AAPL)
Indexiq Etf Tr Hedge Mlti Etf (QAI)
Vaneck Merk Gold Tr Gold Trust (OUNZ)
Berkshire Hathaway Inc Del Cl A (BRK.A)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Ishares Tr Rus 1000 Etf (IWB)
Procter & Gamble Company (PG)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Pitcairn Company

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
Wellington Management Company
T. Rowe Price Associates
Federated Investors
ClearBridge Advisors
Alliancebernstein
Marshall Wace
Baker Bros. Advisors
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Avidity Partners Management
Norges Bank Investment Management
First Light Asset Management
Jacobs Levy Equity Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Ultragenyx Pharmaceutical